OROSOOTHE

This brand name is authorized in Ireland, Malta

Active ingredients

The drug OROSOOTHE contains one active pharmaceutical ingredient (API):

1 Benzydamine UNII K2GI407R4Q - BENZYDAMINE HYDROCHLORIDE
Benzydamine exerts an anti-inflammatory and analgesic action by stabilising the cellular membrane and inhibiting prostaglandin synthesis. Read about Benzydamine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A01AD02	Benzydamine	A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AD Other agents for local oral treatment
Discover more medicines within A01AD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: MT	Medicines Authority	Identifier(s): AA729/30001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.